……. and yet another ADC buyout …. again - just not Starpharma …. Even if Starpharma did a small deal like this is would be circa $2 per share …. perhaps our ADCs just don’t stack up ? Would make sense I suppose given one of our ADC research agreement partners Merck committed up to $22 billion with Daiichi less than 2 months ago
Bristol Myers Squibb claims to be taking on Merck in the ADC space and yet that still hasn’t enticed Merck to secure our ADCs after 2+ years of looking under the hood / performing preclinical ADC studies ?
https://www.fiercebiotech.com/biote...Pharma Tracker&oly_enc_id=9563F4064234D3D
BMS pays $800M upfront for antibody-drug conjugate, opening new front in Merck rivalry
Bristol Myers Squibb has filled the antibody-drug conjugate (ADC) shaped hole in its pipeline by following the increasingly well-trodden path to China, handing SystImmune $800 million upfront for a phase 2 solid tumor candidate as part of a deal worth up to $8.4 billion.
Until now, BMS has been notably absent from the ADC dealmaking frenzy, staying on the sidelines while rivals for the cancer drug market such as AstraZeneca, Gilead and Merck & Co. hoovered up assets. BMS outlined work on ADC degraders at its R&D day in September, explaining how using an antibody to direct a CELMoD to its target could improve efficacy and tolerability but has mostly stayed out of the main fray.
That changed after the market closed Monday when the Big Pharma unveiled a deal for the ex-China rights to the EGFRxHER3 bispecific BL-B01D1. BMS is betting big on the candidate, paying $800 million upfront and committing up to $500 million in near-term milestones to land the asset.
- Forums
- ASX - By Stock
- SPL
- Another ADC Buyout - Just not SPL
Another ADC Buyout - Just not SPL, page-14
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 372123 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 5042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 372123 | 0.099 |
2 | 140000 | 0.098 |
1 | 64565 | 0.097 |
1 | 50000 | 0.095 |
3 | 41738 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 5042 | 1 |
0.105 | 137318 | 2 |
0.110 | 226808 | 10 |
0.115 | 122327 | 4 |
0.120 | 139405 | 10 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |